US FDA approves Emergent BioSolutions' anthrax vaccine

In this article:

July 20 (Reuters) - Emergent BioSolutions said on Thursday the U.S. Food and Drug Administration has approved its anthrax vaccine. (Reporting by Sriparna Roy in Bengaluru)

Advertisement